CYTOMORPHOLOGICAL CATEGORIZATION OF THYROID LESION ACCORDING TO THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOLOGY AND CORRELATION WITH THEIR HISTOLOGICAL OUTCOME AND TIRADS

Main Article Content

Dr Shihij chaku
Dr Surabhi Pandey
Shubhnita Garg
Dr Tanu Agrawal

Keywords

Thyroid Nodule; FNAC; TBSRTC; TIRADS; Cytopathology

Abstract

Background and Aims: Thyroid nodules are common and increasingly detected through imaging. Fine Needle Aspiration Cytology (FNAC) and the Bethesda System (TBSRTC) are widely used for diagnostic stratification. This study aimed to categorize thyroid lesions cytologically per TBSRTC and correlate them with TIRADS classification and histopathological outcomes to enhance diagnostic accuracy.


Methods: This retrospective study was conducted from January 2023 to May 2024 at SRMS-IMS, Bareilly, after ethical committee approval. FNAC samples (22–24G needle) were stained with MGG and Pap stains. Data from 122 cases were analyzed and correlated with TIRADS and histopathology. Descriptive and inferential statistics were applied.


Results: FNAC showed 92% NPV and 100% PPV with 90% sensitivity and 64% specificity. ROM in Bethesda IV and TIRADS 4 was 70% and 50% respectively.


Conclusion: Combining TBSRTC and TIRADS enhances malignancy prediction and improves thyroid nodule management.

Abstract 207 | Pdf Downloads 39

References

1. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2010;16(3):468–75.
2. Vargas-Uricoechea H, Meza-Cabrera M, Herrera-Chaprro J. Concordance between the TIRADS ultrasound criteria and the BETHESDA cytology criteria on the nontoxic thyroid nodule. Thyroid Res. 2017;10:1.
3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):359–86.
4. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
5. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587–95.
6. Ali SZ, Cibas ES, editors. The Bethesda System for Reporting Thyroid Cytopathology. 2nd ed. Cham (Switzerland): Springer International Publishing; 2018.
7. Shankar SP, Meenakshisundaram K, Rajalakshmi V, Selvakumar SA, Giridharan B. The Bethesda System for Reporting Thyroid Cytopathology: A two-year retrospective review in a tertiary care hospital. Indian J Pathol Oncol. 2016;3(1):48–54.
8. Mahajan S, Srinivasan R, Rajwanshi A, Nijhawan R, Dutta P, Gupta N. Risk of malignancy and risk of neoplasia in the Bethesda indeterminate categories: Study on 4,532 thyroid fine-needle aspirations from a single institution in India. Acta Cytol. 2017;61(2):103–10.